Stada, Biogen Bring Greater Ranibizumab Competition To EU And UK

Xbrane’s Ximluci And Samsung Bioepis’ Byooviz Join Teva/Formycon/Bioeq Product

 
• By Dean Rudge

April brings news of further biosimilar competition to Lucentis in major European markets.

Europe from space (Romolo Tavani/Shutterstock.com)
• Source: Shutterstock

More from Biosimilars

More from Products